| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Articles |
From the Department of Medicine (D.W.W., A.L.G.), Vanderbilt University, Nashville, Tenn; Section of Cardiology (L.C., P.J.S.), Department of Lung, Blood and Heart, University of Pavia; Department of Cardiology (L.C., P.J.S.) and Molecular Cardiology Laboratory (L.C., M.P., P.J.S.), IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy; Division of Cardiology (W.S.), Department of Internal Medicine, Department of Pediatric Cardiology (K.K., A.M.), Department of Perinatology (T.I.), National Cardiovascular Center, Osaka, Japan; Department of Cardiology (F.C., P.D.F.), Ospedali Riuniti, Bergamo, Italy; Department of Pharmacology (A.L.G.), Vanderbilt University, Nashville, Tenn.
Correspondence to Alfred L. George Jr, MD, Division of Genetic Medicine, 529 Light Hall, Vanderbilt University, Nashville TN 37232-0275. E-mail al.george{at}vanderbilt.edu
Received April 24, 2008; accepted September 15, 2008.
Background— Inherited cardiac arrhythmia susceptibility contributes to sudden death during infancy and may contribute to perinatal and neonatal mortality, but the molecular basis of this risk and the relationship to genetic disorders presenting later in life is unclear. We studied the functional and pharmacological properties of a novel de novo cardiac sodium channel gene (SCN5A) mutation associated with an extremely severe perinatal presentation of long-QT syndrome in unrelated probands of different ethnicity.
Methods and Results— Two subjects exhibiting severe fetal and perinatal ventricular arrhythmias were screened for SCN5A mutations, and the functional properties of a novel missense mutation (G1631D) were determined by whole-cell patch clamp recording. In vitro electrophysiological studies revealed a profound defect in sodium channel function characterized by
10-fold slowing of inactivation, increased persistent current, slowing of recovery from inactivation, and depolarized voltage dependence of activation and inactivation. Single-channel recordings demonstrated increased frequency of late openings, prolonged mean open time, and increased latency to first opening for the mutant. Subjects carrying this mutation responded clinically to the combination of mexiletine with propranolol and survived. Pharmacologically, the mutant exhibited 2-fold greater tonic and use-dependent mexiletine block than wild-type channels. The mutant also exhibited enhanced tonic (2.4-fold) and use-dependent block (
5-fold) by propranolol, and we observed additive effects of the 2 drugs on the mutant.
Conclusions— Our study demonstrates the molecular basis for a malignant perinatal presentation of long-QT syndrome, illustrates novel functional and pharmacological properties of SCN5A-G1631D, which caused the disorder, and reveals therapeutic benefits of propranolol block of mutant sodium channels in this setting.
Key Words: antiarrhythmia agents arrhythmia death, sudden heart arrest ion channels
Related Article
Circ Arrhythm Electrophysiol 2008 1: 370-378.
|
Home | Subscriptions | Archives | Feedback | Authors | Help | Circulation Journals Home | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |